Androgen receptor (AR): A novel target for radiosensitization and treatment in triple-negative breast cancers (TNBC)

被引:0
|
作者
Speers, Corey [1 ]
Zhao, Shuang G. [1 ]
Liu, Meilan [1 ]
Evans, Joseph [1 ]
Alluri, Prasanna [1 ]
Hayes, Daniel F. [1 ]
Feng, Felix Y. [1 ]
Pierce, Lori J. [1 ]
机构
[1] Univ Michigan Hosp & Hlth Syst, Ann Arbor, MI USA
关键词
D O I
10.1158/1538-7445.SABCS14-P6-03-08
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P6-03-08
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Androgen receptor (AR): A novel target for radiosensitization in triple-negative breast cancers (TNBC)
    Chandler, Benjamin C.
    Speers, Corey W.
    Zhao, Shuang G.
    Liu, Meilan
    Wilder-Romans, Kari
    Olsen, Eric
    Nyati, Shyam
    Spratt, Daniel
    Wahl, Daniel
    Hayes, Daniel
    Feng, Felix Y.
    Pierce, Lori J.
    [J]. CANCER RESEARCH, 2017, 77
  • [2] Androgen receptor (AR): A novel target and mechanism for radiosensitization and treatment in triple negative breast cancers (TNBC)
    Speers, C.
    Zhao, S. G.
    Liu, M.
    Rae, J. M.
    Hayes, D. F.
    Feng, F. Y.
    Pierce, L. J.
    [J]. CANCER RESEARCH, 2016, 76
  • [3] TTK: A novel target for radiosensitization in triple-negative breast cancers
    Chandler, Benjamin C.
    Moubadder, Leah
    Ritter, Cassie
    Niknafs, Yashar
    Olsen, Eric
    Cameron, Meleah
    Liu, Meilan
    Wilder-Romans, Kari
    Nyati, Shyam
    Brown, Powel
    Chinnaiyan, Arul
    Speers, Corey
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [4] P16 Expression is correlated with Androgen Receptor (AR) expression in Triple-Negative Breast Cancers (TNBC)
    Yoon, Esther
    Wilson, Parker
    Irshaid, Lina
    Zuo, Tao
    Pinto, Marguerite
    Cole, Kimberly
    Harigopal, Malini
    [J]. MODERN PATHOLOGY, 2019, 32
  • [5] P16 Expression is correlated with Androgen Receptor (AR) expression in Triple-Negative Breast Cancers (TNBC)
    Yoon, Esther
    Wilson, Parker
    Irshaid, Lina
    Zuo, Tao
    Pinto, Marguerite
    Cole, Kimberly
    Harigopal, Malini
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [6] Integration of Androgen Receptor (AR) Expression to Predict Survival for Triple-Negative Breast Carcinoma (TNBC)
    Astvatsaturyan, Kristine
    Yue, Yong
    Bose, Shikha
    [J]. MODERN PATHOLOGY, 2016, 29 : 30A - 30A
  • [7] Integration of Androgen Receptor (AR) Expression to Predict Survival for Triple-Negative Breast Carcinoma (TNBC)
    Astvatsaturyan, Kristine
    Yue, Yong
    Bose, Shikha
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 30A - 30A
  • [8] Triple Negative Breast Carcinoma (TNBC) and Androgen Receptor (AR) expression
    Kavoura, E.
    Nonni, A.
    Kafiri, G.
    Liakou, P.
    Zografos, G.
    Patsouris, E.
    [J]. VIRCHOWS ARCHIV, 2015, 467 : S57 - S57
  • [9] Radiosensitization of androgen receptor (AR)-positive triple-negative breast cancer (TNBC) cells using seviteronel (SEVI), a selective CYP17 lyase and AR inhibitor.
    Speers, Corey Wayne
    Chandler, Benjamin
    Zhao, Shuang
    Liu, Meilan
    Wilder-Romans, Kari
    Olsen, Eric
    Nyati, Shyam
    Rae, James M.
    Hayes, Daniel F.
    Spratt, Daniel Eidelberg
    Wahl, Daniel Richard
    Feng, Felix Yi-Chung
    Pierce, Lori J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] The predictive role of estrogen receptor beta (ER-β) in androgen receptor (AR)-positive triple-negative breast cancer (TNBC)
    Anestis, A.
    Mihailidou, C.
    Theocharis, S.
    Tryfonopoulos, D.
    Korogiannos, A.
    Koumarianou, A.
    Xingi, E.
    Kontos, M.
    Papavassiliou, A. G.
    Karamouzis, M. V.
    [J]. ANNALS OF ONCOLOGY, 2018, 29